ReNewVax

Liverpool, United Kingdom

ReNewVax develops pneumococcal vaccines to prevent life-threatening bacterial infections.

$326K raised

Oct 2024

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ReNewVax raised?

ReNewVax has raised $326K in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2024.

Who are ReNewVax's investors?

ReNewVax's investors include SFC Capital.

Where is ReNewVax headquartered?

ReNewVax is headquartered in Liverpool, United Kingdom.

What does ReNewVax do?

ReNewVax develops pneumococcal vaccines to prevent life-threatening bacterial infections.

What stage is ReNewVax at?

ReNewVax is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 18, 2024.

MLA

"ReNewVax — Funding & Investors." VCBacked, October 18, 2024, https://www.vcbacked.co/company/renewvax. Accessed July 2, 2026.

APA

VCBacked. (2024). ReNewVax — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/renewvax

Wikipedia (cite web)

{{cite web |title=ReNewVax — Funding & Investors |url=https://www.vcbacked.co/company/renewvax |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 18, 2024.